Special Report By Andrew Joseph Data show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains
Special Report By Damian Garde — STAT and Jonathan Saltzman — Boston Globe The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Special Report By Erin Brodwin Externally polished, internally marginalized: Inside the fight over Pinterest’s health misinformation policy
Special Report By Lev Facher First-of-its-kind examination shows how widely pharma showers campaign cash at the state level
Special Report By Andrew Joseph The Road Ahead: Charting the coronavirus pandemic over the next 12 months — and beyond
Special Report By Erin Brodwin and Rebecca Robbins As Elon Musk’s Neuralink prepares to draw back the curtain, ex-employees describe rushed timelines clashing with science’s slow pace
Special Report By Lev Facher Ramped-up testing and daily briefings: Inside Biden’s plan to take over a tumultuous Covid-19 response
Special Report By Rebecca Robbins and Erin Brodwin How Teladoc won: The inside story of how well-timed bets propelled it ahead of the competition
Special Report By Lev Facher Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
Special Report By Rebecca Robbins and Adam Feuerstein Harry Reid and Alex Trebek tried Patrick Soon-Shiong’s experimental cancer therapy. Can their results be duplicated in a clinical trial?
Special Report By Rebecca Robbins and Erin Brodwin An invisible hand: Patients aren’t being told about the AI systems advising their care
Special Report By Nicholas Florko The CDC has always been an apolitical island. That’s left it defenseless against Trump
Special Report By David Barboza — The Wire After a bribery scandal in China, GSK found a suspected whistleblower. The real one is still waiting in the shadows
Special Report By Megan Thielking Facing a broken mental health system, many U.S. teens fall off a dangerous ‘cliff’ in their care
Special Report By Erin Brodwin and Casey Ross Two years of halting progress and high turnover preceded Atul Gawande’s exit as Haven CEO
Special Report By Nicholas Florko and Damian Garde With remdesivir, Gilead finds itself at strategic crossroads, with its reputation (and far more) at stake
Special Report By Sharon Begley Three potential futures for Covid-19: recurring small outbreaks, a monster wave, or a persistent crisis
Special Report By Gardiner Harris and Alex W. Palmer — The Wire China has near-total control of the world’s antibiotic supply. Is America at risk as a result?
Special Report By Andrew Joseph Coronavirus pandemic threatens to take crushing toll on rural areas, data show
Special Report By Sharon Begley When can we let up? Health experts craft strategies to safely relax coronavirus lockdowns
Special Report By Andrew Joseph As the coronavirus spreads, a drug that once raised the world’s hopes is given a second shot
Special Report By Megan Thielking ‘A Supercenter for health’: Walmart places a big bet on cheaper, less intimidating primary care
Special Report By Natasha Gilbert ‘Dump it down the drain’: How contaminants from prescription-drug factories pollute waterways
Special Report By Eric Boodman The Medicine Hunters, Part II: Toxic weed fuels a cancer-drug gold rush — and a quandary
Special Report By Eric Boodman The Medicine Hunters, Part I: Before signing up for a trial, one patient wants to know if the drug will be affordable
Special Report By Sharon Begley Forecasting Alzheimer’s: With a tsunami of new diagnoses expected, experts calculate the best ways to shift the tide
Special Report By Diana Cai Chinese scientists came to the U.S. to pursue their dreams. Under tighter scrutiny, many are returning home
Special Report By Eric Boodman The vaccine whisperers: Counselors gently engage new parents before their doubts harden into certainty
